GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $339,000 | -9.6% | 1,563 | -51.9% | 0.00% | -25.0% |
| Q4 2020 | $375,000 | -8.8% | 3,251 | -23.0% | 0.00% | -20.0% |
| Q3 2020 | $411,000 | -10.7% | 4,220 | +12.6% | 0.01% | -16.7% |
| Q2 2020 | $460,000 | +56.5% | 3,749 | +11.8% | 0.01% | +20.0% |
| Q1 2020 | $294,000 | -27.4% | 3,354 | -13.4% | 0.01% | -16.7% |
| Q4 2019 | $405,000 | +19.1% | 3,872 | +31.2% | 0.01% | +20.0% |
| Q3 2019 | $340,000 | -69.5% | 2,952 | -54.3% | 0.01% | -68.8% |
| Q2 2019 | $1,113,000 | +5.4% | 6,459 | +3.1% | 0.02% | 0.0% |
| Q1 2019 | $1,056,000 | +97.4% | 6,262 | +14.0% | 0.02% | +60.0% |
| Q4 2018 | $535,000 | -37.3% | 5,491 | +11.2% | 0.01% | -28.6% |
| Q3 2018 | $853,000 | +171.7% | 4,939 | +119.4% | 0.01% | +100.0% |
| Q2 2018 | $314,000 | – | 2,251 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |